Performance of [18F]FDG-PET/CT Imaging in First Recurrence of Invasive Lobular Carcinoma
CONCLUSIONS: FDG-PET/CT is an effective and reliable tool for the detection of invasive lobular carcinoma recurrence, although certain recurrence sites specific to this histological type can impair its diagnostic performance.PMID:37109252 | PMC:PMC10144846 | DOI:10.3390/jcm12082916 (Source: Clinical Breast Cancer)
Source: Clinical Breast Cancer - April 28, 2023 Category: Cancer & Oncology Authors: David Bonnin Sylvain Ladoire Nathalie Briot Aur élie Bertaut Cl ément Drouet Alexandre Cochet Jean-Louis Alberini Source Type: research
Altered cytokeratin 5 expression in breast lobular myoepithelial cells
CONCLUSIONS: These results suggest that CK5 expression in lobular MECs may be altered by contact with cancerous luminal cells rather than benign hyperplastic luminal cells or pressure from dilated glands.PMID:37116947 | DOI:10.1136/jcp-2023-208835 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - April 28, 2023 Category: Cancer & Oncology Authors: Anqi Li Miao Ruan Xiaochun Fei Haimin Xu Shijie Deng Rui Bi Wentao Yang Lei Dong Source Type: research
Performance of [18F]FDG-PET/CT Imaging in First Recurrence of Invasive Lobular Carcinoma
CONCLUSIONS: FDG-PET/CT is an effective and reliable tool for the detection of invasive lobular carcinoma recurrence, although certain recurrence sites specific to this histological type can impair its diagnostic performance.PMID:37109252 | PMC:PMC10144846 | DOI:10.3390/jcm12082916 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - April 28, 2023 Category: Cancer & Oncology Authors: David Bonnin Sylvain Ladoire Nathalie Briot Aur élie Bertaut Cl ément Drouet Alexandre Cochet Jean-Louis Alberini Source Type: research
Pathology-supported genetic testing for the application of breast cancer pharmacodiagnostics: family counselling, lifestyle adjustments and change of medication
CONCLUSION: Validation of PSGT as a three-pronged pharmacodiagnostics tool for generation of adaptive reports and data reinterpretation during follow-up represents a new paradigm in personalised medicine, exposing significant limitations to overcome.PMID:37060281 | DOI:10.1080/14737159.2023.2203815 (Source: Expert Review of Molecular Diagnostics)
Source: Expert Review of Molecular Diagnostics - April 15, 2023 Category: Laboratory Medicine Authors: Abisola O Okunola Karin J Baatjes Annalise E Zemlin Rispah Torrorey-Sawe Magda Conradie Martin Kidd Rajiv T Erasmus Nerina C van der Merwe Maritha J Kotze Source Type: research
